309 related articles for article (PubMed ID: 34292518)
1. Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims.
Senna M; Ko J; Tosti A; Edson-Heredia E; Fenske DC; Ellinwood AK; Rueda MJ; Zhu B; King B
Adv Ther; 2021 Sep; 38(9):4646-4658. PubMed ID: 34292518
[TBL] [Abstract][Full Text] [Related]
2. Comparing the burden of illness in patients with alopecia areata vs atopic dermatitis in the US population from a payer perspective.
Fenske DC; Ding Y; Morrow P; Smith SG; Silver MK; Moynihan M; Manjelievskaia J
J Manag Care Spec Pharm; 2023 Apr; 29(4):409-419. PubMed ID: 36989453
[No Abstract] [Full Text] [Related]
3. All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United States.
Mostaghimi A; Gandhi K; Done N; Ray M; Gao W; Carley C; Wang T; Swallow E; Sikirica V
J Manag Care Spec Pharm; 2022 Apr; 28(4):426-434. PubMed ID: 35332790
[No Abstract] [Full Text] [Related]
4. Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database.
Campos-Alberto E; Hirose T; Napatalung L; Ohyama M
J Dermatol; 2023 Jan; 50(1):37-45. PubMed ID: 36321512
[TBL] [Abstract][Full Text] [Related]
5. Healthcare Utilization and Costs Among US Adolescents With Alopecia Areata.
Ray M; Swallow E; Gandhi K; Carley C; Sikirica V; Wang T; Done N; Signorovitch J; Mostaghimi A
J Health Econ Outcomes Res; 2022; 9(2):11-18. PubMed ID: 35975139
[No Abstract] [Full Text] [Related]
6. Real-World Claims Analyses of Comorbidity Burden, Treatment Pattern, Healthcare Resource Utilization, and Costs in Pediatric Psoriasis.
Edson-Heredia E; Anderson S; Guo J; Zhu B; Malatestinic WN; Wine-Lee L; Swanson E
Adv Ther; 2021 Jul; 38(7):3948-3961. PubMed ID: 34091866
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States.
Huang KP; Mullangi S; Guo Y; Qureshi AA
JAMA Dermatol; 2013 Jul; 149(7):789-94. PubMed ID: 23700152
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological, clinical and economic burden of alopecia areata in Spain: a real-world retrospective study. The PETALO study.
Vañó-Galván S; Figueras-Nart I; Artime E; Díaz-Cerezo S; Núñez M; Iglesias C; Artés M; Huete T
Eur J Dermatol; 2024 Apr; 34(2):163-175. PubMed ID: 38907547
[TBL] [Abstract][Full Text] [Related]
9. Treatment Patterns for Alopecia Areata in the US.
Lee H; Huang KP; Mostaghimi A; Choudhry NK
JAMA Dermatol; 2023 Nov; 159(11):1253-1257. PubMed ID: 37728940
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, management and the associated burden of mental health illness, atopic and autoimmune conditions, and common infections in alopecia areata: protocol for an observational study series.
Harries M; Macbeth AE; Holmes S; Thompson AR; Chiu WS; Gallardo WR; Messenger AG; Tziotzios C; de Lusignan S
BMJ Open; 2021 Nov; 11(11):e045718. PubMed ID: 34785540
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries.
Vañó-Galván S; Egeberg A; Piraccini BM; Marwaha S; Reed C; Johansson E; Durand F; Bewley A
Dermatol Ther (Heidelb); 2024 Apr; 14(4):1027-1037. PubMed ID: 38509379
[TBL] [Abstract][Full Text] [Related]
12. Real world evidence: patients with alopecia areata in Italy.
Perrone V; Sabatino S; Avitabile A; Dovizio M; Leogrande M; Degli Esposti L
Ital J Dermatol Venerol; 2024 Apr; 159(2):182-189. PubMed ID: 38650498
[TBL] [Abstract][Full Text] [Related]
13. Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population.
Mostaghimi A; Gao W; Ray M; Bartolome L; Wang T; Carley C; Done N; Swallow E
JAMA Dermatol; 2023 Apr; 159(4):411-418. PubMed ID: 36857069
[TBL] [Abstract][Full Text] [Related]
14. Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA.
Mostaghimi A; Xenakis J; Meche A; Smith TW; Gruben D; Sikirica V
Dermatol Ther (Heidelb); 2022 Apr; 12(4):1027-1040. PubMed ID: 35381975
[TBL] [Abstract][Full Text] [Related]
15. Treatment patterns and healthcare resource utilization in palmoplantar pustulosis patients in Japan: A claims database study.
Miyazaki C; Sruamsiri R; Mahlich J; Jung W
PLoS One; 2020; 15(5):e0232738. PubMed ID: 32442204
[TBL] [Abstract][Full Text] [Related]
16. Comorbidities in pediatric alopecia areata.
Conic RZ; Tamashunas NL; Damiani G; Fabbrocini G; Cantelli M; ; Bergfeld WF
J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2898-2901. PubMed ID: 32531131
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of alopecia areata and population-wide comorbidities in Germany: analysis of longitudinal claims data.
Augustin M; Ben-Anaya N; Müller K; Hagenström K
Br J Dermatol; 2024 Feb; 190(3):374-381. PubMed ID: 37852247
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database.
George P; Jagun O; Liu Q; Wentworth C; Napatalung L; Wolk R; Anway S; Zwillich SH
J Dermatol; 2023 Sep; 50(9):1121-1128. PubMed ID: 37291688
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study.
Chu SY; Chen YJ; Tseng WC; Lin MW; Chen TJ; Hwang CY; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
J Am Acad Dermatol; 2011 Nov; 65(5):949-56. PubMed ID: 21616562
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune, Inflammatory, Atopic, Thyroid, and Psychiatric Outcomes of Offspring Born to Mothers With Alopecia Areata.
Lee JY; Ju HJ; Han JH; Lee JH; Bae JM; Lee WS; Lee S
JAMA Dermatol; 2023 Jul; 159(7):711-719. PubMed ID: 37223925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
